Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD ® VTP for Low Risk Prostate Cancer
Condition: Low Risk Prostate Cancer Intervention: Drug: TOOKAD VTP Sponsors: Steba Biotech S.A.; International Drug Development Institute; PrimeVigilance LTD Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Cancer | Cancer & Oncology | Erectile Dysfunction | Incontinence | Prostate Cancer | Research | Study